Many p53-regulated EMT- and cancer malignancy-related genes were changed by E2 treatment (Supplementary Fig. 1) [36], but the effect of p53 on the tumor-associated microenvironment (TME) in lung cancer needs to be addressed. This evidence concerns the gene TP53 and cancer.